What is NDC 70771-1324?

70771-1324 is the product NDC for Memantine hydrochloride, Memantine hydrochloride 28 mg/1 capsule, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Memantine hydrochloride?

111 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Memantine hydrochloride NDC 70771-1324

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1324Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1324Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70771-1324-3	7077113240370771132403	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1324-3)Marketed from Apr 8, 2018
70771-1324-4	7077113240470771132404	10 BLISTER PACK in 1 CARTON (70771-1324-4) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70771-1324-2)Marketed from Apr 8, 2018
70771-1324-9	7077113240970771132409	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1324-9)Marketed from Apr 8, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Memantine hydrochloride
Generic name (nonproprietary): memantine hydrochloride
Active ingredients: Memantine hydrochloride — 28 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203293
Marketing start: Apr 8, 2018
Listing expires: Dec 31, 2027
Other FDA classes: NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 70771-1324_900483ef-de89-464c-a324-8bfaa8f137a6SPL ID 900483ef-de89-464c-a324-8bfaa8f137a6SPL set ID ec825bef-2313-45c2-8858-b43197680155RxCUI 996594, 996603, 996609, 996615UNII JY0WD0UA60
Pharmacologic class: N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771132403 followed by a unit qualifier and the quantity

Package 70771-1324-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2024.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1324

What is NDC 70771-1324?: 70771-1324 is the product NDC for Memantine hydrochloride, Memantine hydrochloride 28 mg/1 capsule, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Memantine hydrochloride.
What is the active ingredient?: Memantine hydrochloride.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Memantine hydrochloride?: 111 other product NDCs are listed under this name. See all Memantine hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Memantine hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Memantine hydrochloride	Memantine hydrochloride 7 mg/1	Capsule, Extended releaseOral	Macleods Pharmaceuticals Limited	33342-219	33342-0219-0733342-0219-12
Memantine hydrochloride	Memantine hydrochloride 14 mg/1	Capsule, Extended releaseOral	Macleods Pharmaceuticals Limited	33342-220	33342-0220-0733342-0220-12
Memantine hydrochloride	Memantine hydrochloride 21 mg/1	Capsule, Extended releaseOral	Macleods Pharmaceuticals Limited	33342-221	33342-0221-0733342-0221-12
Memantine hydrochloride	Memantine hydrochloride 28 mg/1	Capsule, Extended releaseOral	Macleods Pharmaceuticals Limited	33342-222	33342-0222-0733342-0222-12
Memantine Hydrochloride	Memantine hydrochloride 5 mg/1	Tablet, Film coatedOral	Carlsbad Technology, Inc.	61442-192	61442-0192-0561442-0192-60
Memantine Hydrochloride	Memantine hydrochloride 10 mg/1	Tablet, Film coatedOral	Carlsbad Technology, Inc.	61442-193	61442-0193-0561442-0193-60
Memantine Hydrochloridememantine	Memantine hydrochloride 7 mg/1	Capsule, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-852	16571-0852-03
Memantine Hydrochloridememantine	Memantine hydrochloride 14 mg/1	Capsule, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-853	16571-0853-0316571-0853-09
Memantine Hydrochloridememantine	Memantine hydrochloride 21 mg/1	Capsule, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-854	16571-0854-03
Memantine Hydrochloridememantine	Memantine hydrochloride 28 mg/1	Capsule, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-855	16571-0855-0316571-0855-09

All 112 Memantine hydrochloride NDCs

Other NDCs under ANDA 203293

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203293
Product	Strength	Form · route	Labeler	Product NDC
Memantine hydrochloride	Memantine hydrochloride 7 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-546
Memantine hydrochloride	Memantine hydrochloride 14 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-547
Memantine hydrochloride	Memantine hydrochloride 21 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-548
Memantine hydrochloride	Memantine hydrochloride 28 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-549
Memantine hydrochloride	Memantine hydrochloride 7 mg/1	Capsule, Extended releaseOral	Zydus Lifesciences Limited	70771-1321
Memantine hydrochloride	Memantine hydrochloride 14 mg/1	Capsule, Extended releaseOral	Zydus Lifesciences Limited	70771-1322
Memantine hydrochloride	Memantine hydrochloride 21 mg/1	Capsule, Extended releaseOral	Zydus Lifesciences Limited	70771-1323